Mark Sawicki | Chief Executive Officer
Cryoport Systems

Mark Sawicki, Chief Executive Officer, Cryoport Systems

Mark Sawicki brings 15 years of business development and sales management experience, having consistently delivered on corporate revenue and market share goals in the pharmaceutical and biotechnology industries. Sawicki was most recently the chief business officer at AAIPharma Services Corporation/Cambridge Major Laboratories Inc. Additionally, he has served in senior business development roles at CMC Biologics and Albany Molecular Research Inc. (AMRI), where he increased revenue at rates far outpacing industry standards. Sawicki holds a bachelor?s in biochemistry from the State University of New York at Buffalo and a Ph.D. in biochemistry from the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. He also received graduate training at the Hauptman Woodard Medical Research Institute. Sawicki has authored a dozen scientific publications in drug discovery with a focus on oncology and immunology.

Appearances:



Day 3: Friday 21st May 2021 - Commercialisation, Pricing & Access @ 12:30

Strengthening the chain of custody data stream in the cell and gene therapy supply chain

·Services and systems integration through consolidation and strategic partnership·Implementation of process and data integration·Optimization of supply chain workflow

Day 3: Friday 21st May 2021 - Commercialisation, Pricing & Access @ 15:30

Panel: Technology Evolution and Supply Chain

last published: 10/May/21 08:45 GMT

back to speakers